MARKET

IIN

IIN

IntriCon
NASDAQ

Real-time Quotes | Nasdaq Last Sale

21.43
+0.76
+3.68%
Closed 16:00 06/24 EDT
OPEN
20.74
PREV CLOSE
20.67
HIGH
21.45
LOW
20.67
VOLUME
71.96K
TURNOVER
--
52 WEEK HIGH
28.16
52 WEEK LOW
9.95
MARKET CAP
194.42M
P/E (TTM)
2381.11
1D
5D
1M
3M
1Y
5Y
Is IntriCon Corporation (IIN) A Good Investment?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn’t the intention, these filings to a certain ex...
Insider Monkey · 06/14 02:30
Announcing: IntriCon (NASDAQ:IIN) Stock Soared An Exciting 344% In The Last Five Years
Buying shares in the best businesses can build meaningful wealth for you and your family. And we've seen some truly...
Simply Wall St. · 05/26 07:13
3 Reasons Why IntriCon Corporation (IIN) Is a Great Growth Stock
Zacks · 05/12 22:25
12 Health Care Stocks Moving In Tuesday's Intraday Session
 
Benzinga · 05/11 16:36
8-K: INTRICON CORP
(EDGAR Online via COMTEX) -- 0000088790 false 0000088790 2021-05-10 2021-05-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 05/11 03:23
Intricon Reports First Quarter 2021 Results
ARDEN HILLS, Minn., May 10, 2021 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international company engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical device...
GlobeNewswire · 05/10 21:05
IntriCon Q1 EPS $0.26 Up From $(0.08) YoY, Sales $31.80M Beat $26.75 Estimate
IntriCon (NASDAQ:IIN) reported quarterly earnings of $0.26 per share. This is a 425 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $31.80
Benzinga · 05/10 20:33
IntriCon EPS beats by $0.26, beats on revenue
IntriCon (IIN): Q1 Non-GAAP EPS of $0.26 beats by $0.26; GAAP EPS of $0.07 beats by $0.07.Revenue of $31.77M (+47.8% Y/Y) beats by $5.02M.Press Release
Seekingalpha · 05/10 20:27
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of IIN. Analyze the recent business situations of IntriCon through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average IIN stock price target is 29.33 with a high estimate of 32.00 and a low estimate of 26.00.
EPS
Institutional Holdings
Institutions: 112
Institutional Holdings: 9.07M
% Owned: 99.92%
Shares Outstanding: 9.07M
TypeInstitutionsShares
Increased
20
365.70K
New
4
79.33K
Decreased
28
349.60K
Sold Out
2
11.34K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.16%
Healthcare Equipment & Supplies
+0.04%
Key Executives
Non-Executive Chairman/Independent Director
Philip Smith
President/Chief Executive Officer/Director
Scott Longval
Chief Financial Officer
Ellen Scipta
Senior Vice President/Director of Sales/Director of Marketing
Michael Geraci
Chief Human Resource Officer
Sara Hill
Senior Vice President
Dennis Gonsior
Director
Mark Gorder
Independent Director
Nicholas Giordano
Independent Director
Raymond Huggenberger
Independent Director
Robert Masucci
Independent Director
Kathleen Pepski
Independent Director
Heather Rider
Declaration Date
Dividend Per Share
Ex-Div Date
--
Dividend USD 0.045
09/12/2001
--
Dividend USD 0.045
06/13/2001
--
Dividend USD 0.045
03/13/2001
--
Dividend USD 0.045
12/13/2000
--
Dividend USD 0.045
09/13/2000
01/01/1999
Dividend USD 0.045
06/13/2000
01/01/1999
Dividend USD 0.045
03/13/2000
01/01/1999
Dividend USD 0.045
12/13/1999
  • All
  • Financials
  • Insiders
More
About IIN
Intricon Corporation is a joint development manufacturer (JDM) of micromedical components, sub-assemblies and final devices. The Company serves as a JDM partner to medical device original equipment manufacturers (OEMs) by designing, developing, engineering, manufacturing, packaging and distributing micromedical products for markets, such as diabetes, peripheral vascular, interventional pulmonology, electrophysiology and hearing healthcare. The Company manufactures microelectronics, micro-mechanical assemblies, high-precision injection-molded plastic components and body-worn devices for medical device manufacturers. It offers medical device manufacturers the capabilities to design, develop, manufacture, package and distribute medical devices. The Company has facilities in facilities in Minnesota, Illinois, California, Singapore, Indonesia and Germany.

Webull offers kinds of IntriCon Corporation stock information, including NASDAQ:IIN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IIN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IIN stock methods without spending real money on the virtual paper trading platform.